Nurix CSO Gwenn Hansen disposes of 1,452 common shares worth $36,982.44PUBT·Sep 1 at 09:19 PMNRIX+3.24%
Nurix Therapeutics to join Wells Fargo Healthcare Conference fireside chatPUBT·Sep 1 at 12:05 PMNRIX+3.24%
Edmond DE Rothschild Holding S.A. Invests $2.18 Million in Nurix Therapeutics, Inc. $NRIXMarket Beat·Aug 21 at 08:09 AMNRIX+3.24%
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 12-Month High - Should You Buy?Market Beat·Aug 19 at 03:00 PMNRIX+3.24%
Royal Bank Of Canada Boosts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00Market Beat·Aug 10 at 04:54 PMNRIX+3.24%
Dimensional Fund Advisors LP Purchases 349,710 Shares of Nurix Therapeutics, Inc. $NRIXMarket Beat·Aug 9 at 07:36 AMNRIX+3.24%
Biotech Stocks At 52-Week Highs - DCTH +22% On Q2 Results, ANRO, COAG, MNPR, NRIXrttnews·Aug 7 at 10:33 AMMNPR-0.84%ANRO-2.34%
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 4,356 Shares of StockMarket Beat·Aug 5 at 11:23 PMNRIX+3.24%SNY-0.20%
Houte Hans Van Sells 4,761 Shares of Nurix Therapeutics (NASDAQ:NRIX) StockMarket Beat·Aug 5 at 11:07 AMNRIX+3.24%
Nurix Therapeutics (NASDAQ:NRIX) Earns Buy Rating from Needham & Company LLCMarket Beat·Aug 4 at 03:24 PMNRIX+3.24%
Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | NRIX Stock NewsStockTitan·Aug 3 at 09:00 PMNRIX+3.24%
